Seaport Therapeutics, Inc. Interest and Other Income
Seaport Therapeutics, Inc. (SPTX) reported Interest and Other Income of $3.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2026-08-03
- Seaport Therapeutics, Inc. interest and other income for the quarter ending 2026-06-30 was $3.21M, a 5.45% decline year-over-year.
- Seaport Therapeutics, Inc. interest and other income for the quarter ending 2026-03-31 was $2.13M, a 30.23% decline year-over-year.
- Seaport Therapeutics, Inc. interest and other income for the quarter ending 2025-06-30 was $3.39M.
- Seaport Therapeutics, Inc. interest and other income for the quarter ending 2025-03-31 was $3.06M.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month |
|---|---|---|
| 2026-06-30 | $3.21M 10-Q · filed 2026-08-03 | $5.34M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $2.13M 10-Q · filed 2026-06-08 | |
| 2025-06-30 | $3.39M 10-Q · filed 2026-08-03 | $6.45M 10-Q · filed 2026-08-03 |
| 2025-03-31 | $3.06M 10-Q · filed 2026-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |